You are here: All Products  > Chi-Med Approved to Market Surufatinib for Neuroendocrine Tumors

Chi-Med Approved to Market Surufatinib for Neuroendocrine Tumors

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products